Should You Add Titan Pharmaceuticals, Inc. common stock (TTNP) Stock to Your Portfolio Tuesday?

Tuesday, December 28, 2021 11:48 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Titan Pharmaceuticals, Inc. common stock (TTNP) Stock to Your Portfolio Tuesday?

Titan Pharmaceuticals, Inc. common stock (TTNP) is near the bottom in its sector according to InvestorsObserver. TTNP gets an overall rating of 9. That means it scores higher than 9% of stocks. Titan Pharmaceuticals, Inc. common stock gets a 29 rank in the Healthcare sector. Healthcare is number 8 out of 11 sectors.

TTNP has an Overall Score of 9. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 9 would rank higher than 9 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Titan Pharmaceuticals, Inc. common stock Stock Today?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is lower by -9% while the S&P 500 has gained 0.02% as of 11:46 AM on Tuesday, Dec 28. TTNP is down -$0.10 from the previous closing price of $1.11 on volume of 166,169 shares. Over the past year the S&P 500 has gained 28.29% while TTNP is down -67.42%. TTNP lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.